The Clinical Significance of the Magee Equations in Breast Cancer Prognostication

TL;DR

The Magee equations offer a cost-effective alternative to expensive genomic tests for breast cancer prognosis, improving access in limited-resource settings.

Contribution

The Magee equations provide a practical and affordable solution for breast cancer recurrence prediction in resource-limited areas.

Findings

The Magee equations can reliably estimate breast cancer recurrence scores.

They offer a cost-effective alternative to genomic assays for prognosis.

They help bridge the gap in access to molecular diagnostics in low-resource settings.

Abstract

The landscape of breast cancer management has been revolutionized by advancements in molecular diagnostics, yet accessibility and cost remain significant barriers for many patients. Limited-resource settings often face significant challenges in accessing expensive molecular tests, which can impact timely diagnosis and treatment decisions. The Magee equations present a practical, cost‐effective solution that can bridge this gap, ensuring that patients, regardless of their financial or geographic limitations, receive appropriate and timely treatment. Originally developed at the University of Pittsburgh Medical Center, these equations offer a reliable alternative for estimating recurrence scores without the prohibitive costs associated with genomic assays.